Back to search

Switzerland· 49748001

Zentel, Kautabletten

A albendazole product containing albendazolum, registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.

Cat B (Swissmedic)ATC P02CA03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedZentel, KautablettenATCP02CA03REGISTER NO.49748001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Albendazole is registered in 10 of 19 countries.

Countries holding a registration under ATC P02CA03 (albendazole), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 6 of them publish a price we can compare per daily dose

Albendazole · ATC P02CA03

10 / 19 countries

  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of albendazole costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $5.63 in France to $36.54 in Switzerland — a ×6.5 gap.

  • Switzerland: $36.54 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Albendazole · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$36.54
  • FR France$5.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
albendazolum
Manufacturer
GlaxoSmithKline AG
Country
Switzerland (CH)
ATC code
P02CA03
ATC class
Albendazole
Defined daily dose
0.8 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

114 interactions on record for albendazole.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Albendazole · interactions on record

114 records

  • 3 severe
  • 102 moderate
  • 9 minor

Most severe, free to view

  • CladribineL01BB04severe
  • CladribineL04AA40severe
  • ClozapineN05AH02severe
  • AprepitantA04AD12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Albendazole in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albendazole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Eskazole
  • Bulgaria · Зентел
  • Cyprus · Zestaval
  • Germany · Albendazol Micro Labs, Eskazole
  • Spain · Eskazole
  • France · Eskazole, Zentel
  • United Kingdom (Northern Ireland) · Albendazole Brown & Burk Uk
  • Greece · Albendol
  • Hungary · Albendazol Pharma Vim
  • Italy · Zentel
  • Luxembourg · Albendazol Micro Labs
  • Malta · Zestaval
  • Netherlands · Eskazole
  • Poland · Zentel
  • Portugal · Zentel
  • Romania · Albendazol Vim Spectrum, Duador
  • Slovakia · Zentel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2aa040d-1c34-41f4-8653-99e0ef9a7500
GET /v1/drugs/f2aa040d-1c34-41f4-8653-99e0ef9a7500?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about albendazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.